Knight Therapeutics Inc.

About Knight Therapeutics Inc.

Knight Therapeutics is focused on building a leading specialty pharmaceutical company for Canada and Latin America, aiming to provide innovative healthcare solutions in these regions.

Products & Services

TAVALISSE

Specialties

Specialty Pharmaceuticals Healthcare Solutions for Canada and Latin America

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 100000000 MR: - FA: US$100 million FAN: 100000000	D: 2025-10-31 FD: 2025-10-31	4 investors
2	RT: Debt T: - FT: Debt	A: 50000000 MR: - FA: US$50 million FAN: 50000000	D: 2025-06-17 FD: 2025-06-17	1 investors
3	RT: Share Acquisition T: - FT: Share Acquisition	A: 786450 MR: - FA: 786,450 FAN: 786450	D: 2024-01-31 FD: 2024-01-31	2 investors
4	RT: Equity Investment T: - FT: Equity Investment	A: 631610 MR: - FA: CAD 631,610 FAN: 631610	D: 2023-03-23 FD: 2023-03-23	2 investors

Debt Latest

2025-10-31

$100.0M

4 investors (Pro only)

Debt 2025-06-17

$50.0M

Share Acquisition 2024-01-31

$786K

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News